Sovaldi Drug Expected To Boost Earnings At Gilead
24 Apr. 2015
Thomson Reuters Deals Intelligence provides up to the minute market reviews and analysis to the Deal Making community globally.
Access industry leading, NVCA Exit Poll, Fundraising, Performance and State of the Market reports.
Ownership Intelligence offers FREE access to rich industry reports, profiles of news making investors, job movements of investment professionals, and much more.
THOMSON REUTERS ON DEMAND
A cost-effective and fast way to purchase individual reports and analytics, and have them delivered to your e-mail in-box by our team of expert analysts.